5 things CDC has done to help rebuild Haiti’s immunization system since the 2010 earthquake
In 2010, an earthquake of high magnitude tore through Haiti, the poorest country in the Western Hemisphere, causing destruction on a scale that most people can’t even imagine. More than 200,000 lives were lost and another 2 million people were displaced when their homes were destroyed. All health services were interrupted, and health indicators, including vaccination rates, plummeted. In the 5 years since the earthquake, CDC has been heavily investing in rebuilding Haiti’s capacity to deliver potent vaccines to every child. Appropriate use of vaccines can stop the spread of vaccine-preventable diseases (VPDs) by reducing the number of people who are at risk of infection and decreasing the likelihood that diseases will cross borders and spread to neighboring countries. Here are a few highlights of CDC support:
1. Ensuring protection against measles and rubella
The issue: Although a dose of measles-rubella (MR) vaccine is routinely recommended for children aged 9-11 months in Haiti, only 59% of Haitian children younger than 1 year of age received MR vaccine in 2011. In general, high coverage (>90%) with two doses of MR vaccine is necessary to ensure that a country’s population is protected from the spread of measles or rubella viruses.
The solution: CDC provided scientific expertise and funding to the Haitian Ministry of Health and Population (MSPP), Pan American Health Organization (PAHO), and United Nations’ Children’s Fund (UNICEF) to implement a national MR vaccination campaign from April to June 2012.
CDC also designed and funded a national vaccination coverage survey to evaluate the success of the MR campaign by determining the percentage of children in the target age group (1-9 years of age) who were vaccinated. A team of 25 CDC-trained Haitian interviewers went door-to-door to administer the questionnaire to 7,000 households with 10,000 children.
The results were encouraging: 91% of children had received at least one dose of MR vaccine during the campaign. Nearly 30% of the children surveyed got their first MR dose during the campaign, and more than half of children had received their second dose, a significant milestone toward providing those children with complete protection against measles and rubella.
The MR vaccination campaign was instrumental in increasing immunity to measles and rubella among children in Haiti.
2. Improving cold storage and maintenance for vaccine supply
The issue: Unreliable energy sources and dependence on propane gas refrigerators left many health facilities without the means to properly store vaccines to keep them potent.
The solution: In 2012-2014, CDC funded the installation of 3 new cold rooms in the central vaccine warehouse and the purchase of 78 solar refrigerators to be used at the department (“state”) level. In 2014, CDC funded and hired a cold chain specialist focal point to advise and assist the immunization program on cold chain projects to ensure safe vaccine storage.
In 2014, CDC also funded a pilot project to monitor remotely the temperature in 15 refrigerators distributed throughout the country. With these refrigerators, an alarm goes off if the temperature inside changes too much to keep the vaccines potent. Results enabled immediate responses from cold chain technicians to address any alarms and make sure that the vaccines were kept at the correct temperature and remained potent.
In 2015, CDC is funding the installation of 49 new refrigerators and the optimization of 153 previously installed solar refrigerators in health facilities.
These infrastructure improvements facilitated the introduction of pentavalent vaccine (the 5-in-1 vaccine that prevents diphtheria, pertussis, tetanus, hepatitis B and Haemophilus Influenzae Type B/Hib) in 2012 and rotavirus vaccine in 2014 and will facilitate the introduction of vaccines that protect against pneumonia in 2015. CDC studies that estimated the magnitude of illness from respiratory and diarrheal diseases in Haiti helped justify the introduction of rotavirus and pneumococcal vaccines and will help in evaluating the impact of those vaccines after introduction.
3. Responding to an unprecedented cholera outbreak
The issue: The cholera outbreak in Haiti since 2010 is one of the largest cholera epidemics ever recorded in a single country. In August and September 2013, MSPP conducted an oral cholera vaccination (OCV) campaign for the first time ever; targeting almost 108,000 persons aged 1 year and older in two affected areas, and needed some help with monitoring and evaluating the campaign.
The solution: In collaboration with MSPP, CDC funded and implemented a vaccine coverage survey which showed that the OCV campaign achieved good coverage.
In 2014, an OCV campaign was implemented in 7 additional communes (districts) in Haiti, targeting almost 200,000 individuals. CDC provided technical assistance during the planning for the campaign, and CDC teams helped monitor the two vaccination rounds. CDC also provided technical assistance for implementation of a coverage survey after the campaign.
4. Routine immunization system strengthening
The issue: The 2010 earthquake devastated an already weak routine immunization system. There was dire need for training immunization staff in order to get the program back on its feet to provide services.
The solution: In March 2014, CDC, MSPP and PAHO trained 30 immunization staff on the use of vaccination recording forms, analysis and interpretation of vaccination data, and calculation of vaccine needs. These trained professionals, in turn, trained vaccinators in health facilities to use the same concepts, enabling them to identify and address weaknesses in the immunization program and to improve vaccine coverage. Participants found the interactive case studies and exercises to be highly instructive and enjoyable, and they requested similar methodologies for future trainings.
5. Shoring up disease detection
The issue: There is a high risk of VPD importation of in Haiti, which can readily spread in the population because of low vaccination coverage and weak sanitation infrastructure. Therefore, a good VPD surveillance system is needed to detect and respond quickly to outbreaks.
The solution: To identify the strengths and weaknesses of VPD surveillance, CDC conducted an evaluation of the VPD surveillance system in 2013. Results showed that identification and reporting of acute flaccid paralysis, which is necessary to identify polio cases, and reporting of tetanus cases in newborns was weak. In addition, some healthcare providers were unfamiliar with VPD case definitions and reporting requirements.
To respond to this need, CDC developed and conducted a 4-day training workshop on VPD surveillance and outbreak response. More than 50 people participated, including epidemiologists, data managers, immunization program managers, and laboratory technicians. All the participants were satisfied with the training, and felt that their knowledge had improved.
CDC also provided financial and technical support to MSPP to establish 6 sentinel sites for rotavirus and meningitis surveillance. Data from those sites will help document the impact of rotavirus and pneumococcal vaccines after they are introduced.
CDC will continue to provide technical and financial support to strengthening immunization services in Haiti. In addition to protecting children in Haiti with life-saving vaccines, these efforts also protect other countries in the Americas from VPD importations. Future projects in Haiti include support for improving valid documentation of vaccine doses administered to children, purchasing of additional solar refrigerators for health facilities, achieving and verifying maternal and neonatal tetanus elimination (Haiti is the only country in the Americas where neonatal tetanus has not been eliminated), and determining the disease burden of chronic hepatitis B virus infection in order to assess the need for introducing a birth dose of hepatitis B vaccine.
- Page last reviewed: February 17, 2015
- Page last updated: February 17, 2015
- Content source:
Notice: Linking to a non-federal site does not constitute an endorsement by HHS, CDC or any of its employees of the sponsors or the information and products presented on the site.